Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
about
Risk of ventricular arrhythmias associated with nonsedating antihistamine drugsInhibition of HERG1 K(+) channels by the novel second-generation antihistamine mizolastineCardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity.Treatment of bronchial asthma with terfenadine; a randomized controlled trial.A study of the clinical efficacy of azelastine in patients with extrinsic asthma, and its effect on airway responsiveness.Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders.Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials.Treatment of itching in atopic eczema with antihistamines with a low sedative profile.New cell models and assays in cardiac safety profiling.Autoregulation of enterochromaffin-like cell histamine secretion via the histamine 3 receptor subtypeMulti-centre double-blind comparison of terfenadine once daily versus twice daily in patients with hay fever.A double-blind comparison of terfenadine and mequitazine in the symptomatic treatment of acute pollinosis.Pharmacology of nasal medications: an update.Pharmacokinetics and dose proportionality of loratadine.Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.In vitro prediction of the terfenadine-ketoconazole pharmacokinetic interaction.Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.Terfenadine Determination Using Different Analytical Methods
P2860
Q28343275-AF583890-FD9C-46CE-89F2-105BC8CD1449Q28344933-017001DE-14F3-4584-8EE8-A8A71203BF2EQ33709824-EB891D32-3C6E-46F3-84F0-8258E6398D08Q34417349-C3414EA6-CE70-440C-A796-1EAC5AC7F8C4Q34418337-50F395A5-2F98-47D6-B005-B6DD30EFC33FQ34988193-3BFD76BC-EB30-4DA3-99FB-B674E9E1F89FQ35627751-D9B13562-E99F-433F-8A8D-342956E91250Q35707267-5248A2FD-5767-453C-97DE-D104220C15EDQ36909315-86993F8E-4411-4F15-BE74-3939B57E38A9Q36987558-57538DB6-3AA7-42E4-996C-8E33AA9667C3Q39537416-97C91883-A332-475F-8905-03A2EE6C5778Q40812741-C3F7B03E-94B2-422E-837C-87AF82C4BFE1Q42981419-1DA94AAA-214E-4E72-BD6C-D461CE286CC3Q44507443-C3DD0D38-0B91-4D9F-BEC5-C83A569FBF57Q49079002-5C4347CE-4197-4621-9B7B-53D144EF3A22Q49166540-02773ABF-BD0B-4DB5-ACC7-1DB1CD1BC768Q53745210-2501DAEE-6031-4FE8-80B5-5242026C508BQ58280411-46369F1F-2C78-4CB0-9A27-F8EE63181509
P2860
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
@en
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
@nl
type
label
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
@en
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
@nl
prefLabel
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
@en
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
@nl
P1433
P1476
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.
@en
P2093
P356
10.2165/00003495-198529010-00002
P577
1985-01-01T00:00:00Z
P6179
1046147854